del Campo, Marta http://orcid.org/0000-0003-2808-3699
Peeters, Carel F. W.
Johnson, Erik C. B.
Vermunt, Lisa
Hok-A-Hin, Yanaika S. http://orcid.org/0000-0001-9713-116X
van Nee, Mirrelijn
Chen-Plotkin, Alice http://orcid.org/0000-0002-3387-2038
Irwin, David J. http://orcid.org/0000-0002-5599-5098
Hu, William T.
Lah, James J.
Seyfried, Nicholas T. http://orcid.org/0000-0002-4507-624X
Dammer, Eric B. http://orcid.org/0000-0003-2947-7606
Herradon, Gonzalo
Meeter, Lieke H. http://orcid.org/0000-0003-4277-0815
van Swieten, John
Alcolea, Daniel
Lleó, Alberto
Levey, Allan I. http://orcid.org/0000-0002-3153-502X
Lemstra, Afina W.
Pijnenburg, Yolande A. L.
Visser, Pieter J. http://orcid.org/0000-0001-8008-9727
Tijms, Betty M. http://orcid.org/0000-0002-2612-1797
van der Flier, Wiesje M. http://orcid.org/0000-0001-8766-6224
Teunissen, Charlotte E. http://orcid.org/0000-0002-4061-0837
Article History
Received: 3 December 2020
Accepted: 28 September 2022
First Online: 10 November 2022
Competing interests
: M.d.C. has been an invited speaker at Eisai. L.V. received a grant for the CORAL consortium by Olink. B.M.T. and P.J.V. are inventors on a patent (WO2020197399A1; owned by Stichting VUmc). D.J.I. is a Scientific Advisory Board Member for Denali Therapeutics. D.A. participated in advisory boards from Fujirebio-Europe and Roche Diagnostics and received speaker honoraria from Fujirebio-Europe, Roche Diagnostics, Nutricia, Krka Farmacéutica S.L., Zambon S.A.U. and Esteve Pharmaceuticals S.A. D.A. declares a filed patent application (WO2019175379 A1 Markers of synaptopathy in neurodegenerative disease). W.M.v.d.F. has performed contract research for Biogen MA and Boehringer Ingelheim. W.M.v.d.F. has been an invited speaker at Boehringer Ingelheim, Biogen MA, Danone, Eisai, WebMD Neurology (Medscape) and Springer Healthcare. W.M.v.d.F. is consultant to Oxford Health Policy Forum CIC, Roche and Biogen MA. W.M.v.d.F. participated in advisory boards of Biogen MA and Roche. All funding is paid to her institution. W.M.v.d.F. is member of the steering committee of PAVE and Think Brain Health. W.M.v.d.F. was associate editor of <i>Alzheimer’s Research & Therapy</i> in 2020/2021. W.M.v.d.F. is associate editor at <i>Brain</i>. C.E.T. has a collaboration contract with ADx Neurosciences, Quanterix and Eli Lilly and performed contract research or received grants from AC-Immune, Axon Neurosciences, Bioconnect, Bioorchestra, Brainstorm Therapeutics, Celgene, EIP Pharma, Eisai, Grifols, Novo Nordisk, PeopleBio, Roche, Toyama and Vivoryon. She serves on editorial boards of Medidact Neurologie/Springer, <i>Alzheimer’s Research & Therapy</i> and <i>Neurology: Neuroimmunology & Neuroinflammatio</i>n and is editor of a <i>Neuromethods</i> book (Springer). She had speaker contracts for Roche, Grifols and Novo Nordisk. The other authors declare no competing interests.